© 2021 FLARE THERAPEUTICS INC. ALL RIGHTS RESERVED.
Abbie Celniker, Ph.D.
Interim Chief Executive OfficerEDUCATION
B.A., Biology, University of California, San Diego
Ph.D., Molecular Biology, University of Arizona College of Medicine
PREVIOUS EXPERIENCE
Genentech
Genetics Institute
Wyeth Biotech
Millennium Pharmaceuticals
Novartis
Taligen Therapeutics
Eleven Biotherapeutics
Abbie’s Flare characteristics: A strong commitment to culture. Diverse, experienced teams.
With over 30 years of experience in Senior R&D and Executive leadership roles, Abbie not only focuses on the formation, development and strategy of our portfolio companies, she is fully enveloped in the health of each venture.
With a start-up mentality, Abbie is eager to use her industry expertise to build innovative companies from the ground up, and passionate about tackling the toughest disease challenges in medicine.
She loves spending time with her family and dogs, skiing, kayaking, cooking and doing puzzles.
WHAT IS YOUR ATTRIBUTE THAT YOU CONTRIBUTE TO FLARE?
Some of my proudest accomplishments have been associated with seeing how young, courageous leaders develop and evolve when they are mentored and given encouragement to take risk and spread their wings.
WHAT MAKES YOU EXCITED TO ‘BRING IT’ EVERY DAY AT WORK?
Knowing that we are focused on putting new tools in the hands of healthcare providers so that they can change the lives of patients and their families.